Synthesis and Antimitotic/Cytotoxic Activity of Hemiasterlin Analogues
Journal of Natural Products2002Vol. 66(2), pp. 183–199
Citations Over TimeTop 10% of 2002 papers
James A. Nieman, John E. Coleman, Debra J. Wallace, Edward Piers, Lynette Lim, Michel Roberge, Raymond J. Andersen
Abstract
The antimitotic sponge tripeptide hemiasterlin (1) and a number of structural analogues have been synthesized and evaluated in cell-based assays for both cytotoxic and antimitotic activity in order to explore the SAR for this promising anticancer drug lead. One synthetic analogue, SPA110 (8), showed more potent in vitro cytotoxicty and antimitotic activity than the natural product hemiasterlin (1), and consequently it has been subjected to thorough preclinical evaluation and targeted for clinical evaluation. The details of the synthesis of hemiasterlin (1) and the analogues and a discussion of how their biological activities vary with their structures are presented in this paper.
Related Papers
- → Synthesis and Structure–Activity Relationship Studies of C2-Modified Analogs of the Antimycobacterial Natural Product Pyridomycin(2020)22 cited
- → Design, synthesis, and structure–activity relationship studies of the anaephene antibiotics(2021)8 cited
- → Total Synthesis and Semi-Synthetic Approaches to Analogues of Antibacterial Natural Product Althiomycin(2002)42 cited
- → Bispericyclic Diels–Alder Dimerization of ortho‐Quinols in Natural Product (Bio)Synthesis: Bioinspired Chemical 6‐Step Synthesis of (+)‐Maytenone(2021)4 cited
- → Design of novel tripeptides with macrophage migration-enhancing activity(1998)6 cited